MDS Podcast

Dr. Michele Matarazzo interviews Dr. Amy Amara, the first author of the article awarded as "2020 Research Article from Movement Disorders " on the effects of exercise on sleep in Parkinson's disease. Read the article

In this interview, Prof. Günther Deuschl highlights the main results of the EARLYSTIM project, focusing on non-motor outcomes, and especially on the effects of DBS on Social and Occupational Functioning in Parkinson's Disease. Read the article

Preprint articles of scientific results have been thrust into the spotlight due to the desire for rapid results pertaining to COVID-19. Here, we dive into the trend with Movement Disorders’ editor, Dr. Jon Stoessl. Read the article

Dr. Michele Matarazzo interviews Dr. Anette Schrag about the recently published article on late-stage parkinsonism and related neuropsychiatric complications. Why is it important? And are we doing enough to help patients at this stage? Read the article

Dr. Michele Matarazzo interviews Prof. Roy Alcalay on the effects that the COVID-19 pandemic is having on the clinical activity and how it is changing the way we see patients. Will telemedicine be an integrating part of our clinical practice?

In this interview the president of the MDS, Prof. Claudia Trenkwalder shares the main changes and strategies that the MDS is implementing to adapt to the COVID-19 pandemic, including the replacement of the International MDS congress with a virtual meeting.

Dr. Michele Matarazzo interviews Prof. Angelo Antonini on the effect of the COVID-19 pandemic on Parkinson's disease and other movement disorders patients and how to manage them. And also, what is the evidence of a link between COVID-19 and Parkinson's disease? Read the article

In this issue Dr. Filip Sheperjans shares the results of the article published in the March 2020 issue of the Movement Disorders journal on the effect of antibiotic exposure on the risk of developing Parkinson's disease. Read the article

Dr. Sara Schaefer discusses with Dr. Sarah Lidstone her recent paper in Movement Disorders Clinical Practice about a novel, multidisciplinary therapeutic intervention for functional movement disorders patients. Read the article

Dr. Viswas Dayal discusses with Dr. Michele Matarazzo how adjusting the pulse width of deep brain stimulation could impact Parkinson's disease, highlighting the results of the paper he recently published in the Movement Disorders journal. Read the article

Dr. Sara Schaefer discusses with Dr. Sarah Gregory her recent study on neuroimaging changes and fluid biomarkers in Huntington's disease, and how those may be used to better characterize the biological basis for neurodegeneration in this disease Read the article

Dr. Sara Schaefer speaks with Dr. Nicola Pavese about the imaging modalities currently in use and emerging to differentiate parkinsonian syndromes and Parkinson's subtypes, and how imaging helps us to understand, study, and treat these conditions. Read the article

As part of the MDS Congress 2019 Special Issue, Dr. Michele Matarazzo interviews Dr. Rodger Elble about recent advances in tremor classification, diagnosis and treatment approaches, and about the future plans of the MDS Tremor study group to overcome current challenges for clinicians and researchers.

As part of the MDS Congress 2019 Special Issue, Dr. Michele Matarazzo interviews Dr. Christos Ganos about the newly created MDS Tic Disorders and Tourette Syndrome Study Group, and the main news breakthroughs in the field, that have been discussed during the MDS Congress.

As part of the MDS Congress 2019 Special Issue, Dr. Matarazzo interviews Dr. K. Ray Chaudhuri about news in Parkinson’s disease and Lewy body dementia, including new treatments, scales and other advances in early and late-stage PD. Read the article

As part of the MDS Congress 2019 Special Issue, Dr. Matarazzo interviews Dr. Alberto Espay about technology in movement disorders, highlighting recent advances and the goal of the MDS to create a platform that will combine technology-based data and e-diaries.

As part of the MDS Congress 2019 Special Issue, Dr. Michele Matarazzo interviews Dr. Gesine Respondek about atypical parkinsonisms, focusing on the MDS activities to advance in the knowledge and management of these diseases and facilitate clinical trials.

Dr. Sara Schaefer discusses with Dr. Jordan Kamel the role of botulinum toxin in the treatment of refractory upper limb tremor, and his center's tailored approach to provide relief for these patients. Read the article

As part of the MDS Congress 2019 Special Issue, Dr. Sara Schaefer interviews Dr. Antonio Strafella about the emerging research in neuroimaging in movement disorders and plans to establish a centralized database for neuroimaging in atypical parkinsonisms.

As part of the MDS Congress 2019 Special Issue, Dr. Sara Schaefer interviews Dr. Hyder Jinnah about notable research in dystonia and activities of the MDS Dystonia Study Group.

As part of the MDS Congress 2019 Special Issue, Dr. Schaefer and Dr. Sarah Tabrizi discuss the evolving research in disease-modifying therapies for Huntington's Disease, and what may come next. Read the article

Did you miss the MDS Congress in Nice, or do you just want an overview of highlights from the International Congress as well as a look forward at new ventures? Dr. Schaefer introduces the MDS Congress 2019 special issue, which features interviews with experts in various fields of movement disorders at the MDS Congress 2019. In this first issue, Dr. Sara Schaefer interviews Dr. Kathrin LaFaver abou...

As part of the MDS Congress 2019 Special Issue, Dr. Sara Schaefer interviews Dr. Ronald Postuma about all of the educational offerings through the MDS, as well as new projects of the MDS Education Committee.

In this interview with Dr. Edwin Jabbari, we highlight the results of his study on the definition and genetic and neuropathological characteristics of early onset progressive supranuclear palsy. The full study is available on the September 2019 issue of the Movement Disorders journal. Read the article

Dr. Farwa Ali discusses with Dr. Sara Schaefer the results of her study on the use of the MDS criteria for PSP with the MAX rules and their clinical implications, as well as the challenges of the phenotype variability of this disease in clinical practice and research. Read the article